We analysed presentation, treatment and survival in a representative population-based sample of 3753 Italian colorectal cancer cases, diagnosed 2003-05: 70% were >65 years, 44% stage I-II, 27% stage IV and 92% received surgery. Chemotherapy was given to 58% of stage III colon cases, radiotherapy to 25% of rectal cases. Four percent of surgical cases underwent endoscopic polypectomy, and in 57% ≥11 lymph nodes were examined. Five-year relative survival was good (60%), independent of sex and site. Adherence to treatment guidelines was satisfactory, but wider use of faecal blood testing and colonoscopy will anticipate stage at diagnosis and likely improve survival.
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study / Minicozzi, Pamela; Kaleci, Shaniko; Maffei, Stefania; Allemani, Claudia; Giacomin, Adriano; Caldarella, Adele; Iachetta, Francesco; Fusco, Mario; Tumino, Rosario; Vicentini, Massimo; Falcini, Fabio; Cesaraccio, Rosaria; Ponz De Leon, Maurizio; Sant, Milena. - In: EUROPEAN JOURNAL OF PUBLIC HEALTH. - ISSN 1101-1262. - ELETTRONICO. - 24:1(2014), pp. 98-100. [10.1093/eurpub/ckt056]
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study
KALECI, SHANIKO;MAFFEI, Stefania;IACHETTA, Francesco;PONZ DE LEON, Maurizio;
2014
Abstract
We analysed presentation, treatment and survival in a representative population-based sample of 3753 Italian colorectal cancer cases, diagnosed 2003-05: 70% were >65 years, 44% stage I-II, 27% stage IV and 92% received surgery. Chemotherapy was given to 58% of stage III colon cases, radiotherapy to 25% of rectal cases. Four percent of surgical cases underwent endoscopic polypectomy, and in 57% ≥11 lymph nodes were examined. Five-year relative survival was good (60%), independent of sex and site. Adherence to treatment guidelines was satisfactory, but wider use of faecal blood testing and colonoscopy will anticipate stage at diagnosis and likely improve survival.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
